Total Payments
$66,222
2024 Payments
$4,932
Companies
53
Transactions
993
Medicare Patients
2,789
Medicare Billing
$258,264
Payment Breakdown by Category
Other$46,900 (70.8%)
Food & Beverage$17,564 (26.5%)
Consulting$1,600 (2.4%)
Travel$81.98 (0.1%)
Education$76.33 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,900 | 31 | 70.8% |
| Food and Beverage | $17,564 | 954 | 26.5% |
| Consulting Fee | $1,600 | 2 | 2.4% |
| Travel and Lodging | $81.98 | 1 | 0.1% |
| Education | $76.33 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $46,689 | 50 | $0 (2020) |
| ABBVIE INC. | $4,380 | 223 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,796 | 138 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,875 | 137 | $0 (2024) |
| CapsoVision, Inc. | $1,600 | 2 | $0 (2024) |
| Gilead Sciences, Inc. | $1,230 | 54 | $0 (2024) |
| QOL Medical, LLC | $1,159 | 44 | $0 (2024) |
| Janssen Biotech, Inc. | $758.64 | 57 | $0 (2024) |
| Braintree Laboratories, Inc. | $422.82 | 26 | $0 (2024) |
| Celgene Corporation | $417.86 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,932 | 161 | CapsoVision, Inc. ($1,600) |
| 2023 | $2,790 | 147 | AbbVie Inc. ($812.78) |
| 2022 | $2,856 | 156 | ABBVIE INC. ($753.86) |
| 2021 | $2,688 | 152 | AbbVie Inc. ($642.07) |
| 2020 | $4,690 | 127 | Allergan, Inc. ($2,000) |
| 2019 | $17,917 | 157 | Allergan Inc. ($15,537) |
| 2018 | $15,086 | 46 | Allergan Inc. ($14,400) |
| 2017 | $15,263 | 47 | Allergan Inc. ($14,752) |
All Payment Transactions
993 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $13.30 | General |
| Category: Elastography | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $15.07 | General |
| Category: GI | ||||||
| 11/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA, REMICADE | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Immunology | ||||||
| 11/25/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $104.10 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/06/2024 | CapsoVision, Inc. | CapsoCam Colon (Device) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Immunology | ||||||
| 10/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 493 | 504 | $248,792 | $48,700 |
| 2022 | 17 | 639 | 666 | $303,593 | $63,293 |
| 2021 | 20 | 802 | 848 | $324,518 | $78,235 |
| 2020 | 23 | 855 | 937 | $281,235 | $68,036 |
Total Patients
2,789
Total Services
2,955
Medicare Billing
$258,264
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 82 | 82 | $72,160 | $15,679 | 21.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 88 | 88 | $70,400 | $8,513 | 12.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 67 | 68 | $27,200 | $4,985 | 18.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 26 | 26 | $18,746 | $4,367 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 69 | $9,300 | $4,207 | 45.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $13,022 | $2,651 | 20.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $11,647 | $2,532 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 23 | $4,705 | $1,936 | 41.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $9,780 | $1,522 | 15.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $3,360 | $1,285 | 38.2% |
| 43450 | Dilation of esophagus | Facility | 2023 | 21 | 21 | $7,350 | $569.54 | 7.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 24 | $240.00 | $201.60 | 84.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 14 | 14 | $462.00 | $144.90 | 31.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 14 | 14 | $420.00 | $106.54 | 25.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 106 | 106 | $93,280 | $19,883 | 21.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 101 | 101 | $80,800 | $11,803 | 14.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 84 | 85 | $34,000 | $6,377 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 86 | $10,320 | $5,151 | 49.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 21 | 21 | $16,086 | $3,678 | 22.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 28 | 28 | $17,164 | $3,668 | 21.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 19 | 19 | $13,699 | $3,314 | 24.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $7,200 | $2,556 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,050 | $1,819 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 17 | $3,145 | $1,560 | 49.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 18 | 19 | $9,291 | $1,486 | 16.0% |
About Dr. Brian Smith, M.D
Dr. Brian Smith, M.D is a Gastroenterology healthcare provider based in Shelby, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215908272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Smith, M.D has received a total of $66,222 in payments from pharmaceutical and medical device companies, with $4,932 received in 2024. These payments were reported across 993 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($46,900).
As a Medicare-enrolled provider, Smith has provided services to 2,789 Medicare beneficiaries, totaling 2,955 services with total Medicare billing of $258,264. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Shelby, NC
- Active Since 01/30/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1215908272
Products in Payments
- LINZESS (Drug) $40,919
- VIBERZI (Drug) $6,004
- ENTYVIO (Biological) $2,124
- CapsoCam Colon (Device) $1,600
- XIFAXAN (Drug) $1,065
- RINVOQ (Biological) $846.49
- Sucraid (Drug) $788.43
- SKYRIZI (Biological) $752.78
- HUMIRA (Biological) $728.28
- STELARA (Biological) $628.79
- TRULANCE (Drug) $515.93
- Humira (Biological) $508.67
- CREON (Drug) $416.66
- ZEPOSIA (Drug) $410.02
- SUCRAID (Drug) $370.72
- Linzess (Drug) $364.15
- XELJANZ (Drug) $337.26
- MAVYRET (Drug) $301.82
- DIFICID (Drug) $281.34
- PLENVU (Drug) $271.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.